416 related articles for article (PubMed ID: 29940303)
1. Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.
Francis JH; Roosipu N; Levin AM; Brodie SE; Dunkel IJ; Gobin YP; Abramson DH
Neoplasia; 2018 Aug; 20(8):757-763. PubMed ID: 29940303
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
Francis JH; Iyer S; Gobin YP; Brodie SE; Abramson DH
Ophthalmology; 2017 Oct; 124(10):1548-1555. PubMed ID: 28545735
[TBL] [Abstract][Full Text] [Related]
4. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
[TBL] [Abstract][Full Text] [Related]
5. Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival.
Francis JH; Levin AM; Zabor EC; Gobin YP; Abramson DH
PLoS One; 2018; 13(5):e0197081. PubMed ID: 29791475
[TBL] [Abstract][Full Text] [Related]
6. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy).
Abramson DH; Marr BP; Francis JH; Dunkel IJ; Fabius AW; Brodie SE; Mondesire-Crump I; Gobin YP
PLoS One; 2016; 11(6):e0156806. PubMed ID: 27258771
[TBL] [Abstract][Full Text] [Related]
9. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
10. Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma.
Abramson DH; Daniels AB; Marr BP; Francis JH; Brodie SE; Dunkel IJ; Gobin YP
PLoS One; 2016; 11(1):e0146582. PubMed ID: 26756643
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review.
Abramson DH; Marr BP; Brodie SE; Dunkel I; Palioura S; Gobin YP
PLoS One; 2012; 7(4):e34120. PubMed ID: 22545080
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic artery chemosurgery for retinoblastoma prevents new intraocular tumors.
Abramson DH; Francis JH; Dunkel IJ; Marr BP; Brodie SE; Gobin YP
Ophthalmology; 2013 Mar; 120(3):560-565. PubMed ID: 23177361
[TBL] [Abstract][Full Text] [Related]
13. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
14. Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery.
Rowlands MA; Mondesire-Crump I; Levin A; Mauguen A; Francis JH; Dunkel IJ; Brodie SE; Gobin YP; Abramson DH
PLoS One; 2018; 13(4):e0195395. PubMed ID: 29698399
[TBL] [Abstract][Full Text] [Related]
15. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and results of an intraarterial chemotherapy program for the conservative treatment of retinoblastoma in Argentina.
Funes S; Sampor C; Villasante F; Fandiño A; Manzitti J; Sgroi M; Neira P; Peralta L; Lagomarsino E; Schaiquevich P; Ceciliano A; Chantada GL
Pediatr Blood Cancer; 2018 Aug; 65(8):e27086. PubMed ID: 29693791
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results.
Abramson DH; Marr BP; Dunkel IJ; Brodie S; Zabor EC; Driscoll SJ; Gobin YP
Br J Ophthalmol; 2012 Apr; 96(4):499-502. PubMed ID: 22053101
[TBL] [Abstract][Full Text] [Related]
18. Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC.
Abramson DH; Fabius AW; Issa R; Francis JH; Marr BP; Dunkel IJ; Gobin YP
PLoS One; 2015; 10(12):e0145436. PubMed ID: 26709699
[TBL] [Abstract][Full Text] [Related]
19. Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes.
Levin AM; Francis JH; McFadden M; Brodie S; Gobin YP; Abramson DH
PLoS One; 2019; 14(1):e0210647. PubMed ID: 30650131
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions.
Cobbs LV; Francis JH; Dunkel IJ; Gobin YP; Brodie SE; Abramson DH
Pediatr Blood Cancer; 2021 May; 68(5):e28845. PubMed ID: 33355996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
